Compound E, chemically designated as 209986-17-4 (CAS), represents a significant study within the field of Alzheimer's condition research. This γ-secretase inhibitor was initially developed as a possible therapeutic https://gerardnxlx474438.blogdigy.com/γ-secretase-blocker-compound-e-209986-17-4-64927524